<iframe src="http://www.npr.org/player/embed/1130197/130197" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
NPR's Joanne Silberner has a report on the abortion pill, RU 486. It's been nearly a year since the FDA approved the drug, and a new survey shows far fewer doctors than expected are offering it, though interest may be growing.
NPR thanks our sponsors
Become an NPR sponsor